Microfluidics for Drug Delivery and Nanomedicine

Microfluidic systems play a pivotal role in the development of advanced drug delivery and nanomedicine technologies. By providing precise control over fluid flow and particle manipulation, microfluidics enables the design and fabrication of nano-carriers like liposomes, nanoparticles, and dendrimers, which can encapsulate therapeutic agents for targeted drug delivery. These nano-carriers enhance the bioavailability and stability of drugs, making treatments more effective and reducing side effects. In nanomedicine, microfluidics aids in the creation of nanoscale materials that can deliver drugs, genes, or biologics directly to disease sites, such as tumors, while minimizing damage to healthy tissues. By controlling the size, shape, and surface properties of these nano-carriers, microfluidic devices ensure optimal targeting and controlled release, which is especially crucial for cancer therapies and chronic disease management.Moreover, microfluidic platforms facilitate high-throughput screening of drug candidates, speeding up the drug development process. These systems offer the potential to design personalized treatments, as microfluidics can integrate real-time diagnostics and drug testing, paving the way for precision medicine.As research progresses, microfluidics continues to advance nanomedicine, enabling more efficient, effective, and patient-specific drug delivery systems.

    Related Conference of Microfluidics for Drug Delivery and Nanomedicine

    September 15-16, 2025

    4th International Conference on Microfluidics

    Paris, France

    Microfluidics for Drug Delivery and Nanomedicine Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in